Nicotinamide inhibits melanoma in vitro and in vivo

BACKGROUND: Even though new therapies are available against melanoma, novel approaches are needed to overcome resistance and high-toxicity issues. In the present study the anti-melanoma activity of Nicotinamide (NAM), the amide form of Niacin, was assessed in vitro and in vivo. METHODS: Human (A375,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: Scatozza, Francesca, Moschella, Federica, D’Arcangelo, Daniela, Rossi, Stefania, Tabolacci, Claudio, Giampietri, Claudia, Proietti, Enrico, Facchiano, Francesco, Facchiano, Antonio
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7542872/
https://ncbi.nlm.nih.gov/pubmed/33028392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01719-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars